Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous co (Q42781499)
Jump to navigation
Jump to search
scientific article published on December 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous co |
scientific article published on December 2010 |
Statements
1 reference
Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous co (English)
1 reference
1 reference
1 reference
Sharon-Lise T Normand
1 reference
Michael Pencina
1 reference
Dean J Kereiakes
1 reference
Donald E Cutlip
1 reference
Laura Mauri
1 reference
Stephen D Wiviott
1 reference
David J Cohen
1 reference
David R Holmes
1 reference
1 December 2010
1 reference
1 reference
160
1 reference
6
1 reference
1035-41, 1041.e1
1 reference
Identifiers
1 reference
1 reference